ArticleBritish journal of cancer2018

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis.

David E Gerber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.